FDA Approves First Generic Truvada in US
UPDATED June 9, 2017 // The US Food and Drug Administration (FDA) has approved the first generic version of emtricitabine/tenofovir disoproxil (Truvada, Gilead Sciences) to both treat and prevent HIV infections in this country, the agency announced today.
The manufacturer of the generic is Teva Pharmaceutical Industries. However, the leader of an HIV prevention organization told Medscape Medical News that more generic drug makers are likely to introduce their versions of emtricitabine/tenofovir disoproxil.
FULL STORY: http://www.medscape.com/viewarticle/881368